EditorialIn vitro radiosensitivity and normal tissue damage
References (6)
- et al.
Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients
Int. J. Radiat. Oncol. Biol. Phys.
(1993) - et al.
Radiotherapeutic management of medulloblastoma in a pediatric patient with telangiectasia
Int. J. Radiat. Oncol. Biol. Phys.
(1987) - et al.
Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer
Radiother. Oncol.
(2000)
Cited by (19)
Individual Radiosensitivity Measured With Lymphocytes May Predict the Risk of Acute Reaction After Radiotherapy
2008, International Journal of Radiation Oncology Biology PhysicsCitation Excerpt :The latter applies especially to tumor entities for which dose escalation is possible, such as those of the prostate, head and neck, and lung. It was calculated that such an individualization of radiotherapy might improve the overall success rate by more than 20% (13–16). The association between individual radiosensitivity and the risk of acute effects after radiotherapy appears to be less evident, with some reports showing a clear association but also others showing no obvious correlation (17–31).
Genetic determination of chromosomal radiosensitivities in G0- and G2-phase human lymphocytes>
2007, Radiotherapy and OncologyRadiation-induced damage to normal tissues after radiotherapy in patients treated for gynecologic tumors: Association with single nucleotide polymorphisms in XRCC1, XRCC3, and OGG1 genes and in vitro chromosomal radiosensitivity in lymphocytes
2005, International Journal of Radiation Oncology Biology PhysicsClonogenic survival and cytokinesis-blocked binucleation of skin fibroblasts and normal tissue complications in soft tissue sarcoma patients treated with preoperative radiotherapy
2004, Radiotherapy and OncologyCitation Excerpt :Some studies suggest a trend between in vitro endpoints and the clinical reaction of patients to radiotherapy [3,8,45], while others have failed to establish this link [7,15,16,54]. Despite a significant investment into these predictive assays, their potential use in the clinic remains questionable [9,44,52]. The reasons for the minimal success in attempts to use in vitro cell survival and DNA damage responses after radiation exposure to predict clinical radiation reactions in patients remain unclear, but is likely related to the fact that cell survival and DNA damage repair are only two of numerous factors influencing radiation-induced normal tissue responses.